[
    [
        {
            "time": "2021-08-04",
            "original_text": "A股融资融券日报：两融余额增加114.45亿元（8月4日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "增加",
                    "A股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加114.45亿元（8月4日）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-04",
            "original_text": "复星医药AH股高开兼创历史新高 子公司拟参与医疗保健供应商NFH私有化",
            "features": {
                "keywords": [
                    "复星医药",
                    "AH股",
                    "高开",
                    "私有化",
                    "NFH"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "复星医药AH股高开兼创历史新高 子公司拟参与医疗保健供应商NFH私有化",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-04",
            "original_text": "港股异动︱复星医药(02196)高开4.22% 复星实业拟以置换股份的方式参与NFH私有化 获中国证监会核准非公开发行不超过约1.28亿股A股",
            "features": {
                "keywords": [
                    "复星医药",
                    "高开",
                    "私有化",
                    "证监会",
                    "非公开发行"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股异动︱复星医药(02196)高开4.22% 复星实业拟以置换股份的方式参与NFH私有化 获中国证监会核准非公开发行不超过约1.28亿股A股",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-04",
            "original_text": "港股早评：恒指低开0.14% 电子烟大跌 药品股强势 复星医药创新高",
            "features": {
                "keywords": [
                    "恒指",
                    "低开",
                    "药品股",
                    "复星医药",
                    "创新高"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股早评：恒指低开0.14% 电子烟大跌 药品股强势 复星医药创新高",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-04",
            "original_text": "对抗德尔塔新药物来了？国药集团大动作！900亿疫苗巨头传利好",
            "features": {
                "keywords": [
                    "德尔塔",
                    "新药物",
                    "国药集团",
                    "疫苗",
                    "利好"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "对抗德尔塔新药物来了？国药集团大动作！900亿疫苗巨头传利好",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]